CASI Pharmaceuticals
CASI
#10160
Rank
HK$0.15 B
Marketcap
HK$7.46
Share price
-7.98%
Change (1 day)
-63.42%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2025 (TTM): -HK$21.61

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$21.59. In 2024 the company made an earnings per share (EPS) of -HK$19.96 a decrease over its 2023 EPS that were of -HK$15.75.

EPS history for CASI Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$21.618.27%
2024-HK$19.9626.73%
2023-HK$15.75-32.89%
2022-HK$23.4711.9%
2021-HK$20.97-38.44%
2020-HK$34.07-8.96%
2019-HK$37.4250%
2018-HK$24.9577.78%
2017-HK$14.035.88%
2016-HK$13.25-22.73%
2015-HK$17.15-76.09%
2014-HK$71.72318.18%
2013-HK$17.15-71.79%
2012-HK$60.8165.96%
2011-HK$36.64-50%
2010-HK$73.28-18.97%
2009-HK$90.43-63.64%
2008-HK$248.693.57%
2007-HK$240.11-60.56%
2006-HK$608.8697.22%
2005-HK$308.72-2.7%
2004-HK$317.29-45.59%
2003-HK$583.13-61.8%
2002-HK$1,526-25.52%
2001-HK$2,050-21.38%
2000-HK$2,60713.86%
1999-HK$2,290149.53%
1998-HK$917.5898.15%
1997-HK$463.0810.2%
1996-HK$420.20